EU Novel Food Regulation (EC) 2015/2283Regulation (EU) 2015/2283 on Novel Foods
Regulation (EU) 2015/2283 sets the EU-wide gate that any food not used for human consumption to a significant degree in the Union before 15 May 1997 must pass through before it can be placed on the market, via either a full EFSA-assessed authorisation or a lighter notification route for foods with a long history of safe use outside the Union.

On this page · 5 sections
How does EU Novel Food Regulation (EC) 2015/2283 apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01What counts as a novel food under Article 3
Regulation (EU) 2015/2283 defines a novel food, in Article 3(2)(a), as any food that was not used for human consumption to a significant degree within the Union before 15 May 1997, irrespective of when individual Member States joined the Union, provided it also falls under at least one of ten listed categories. The cut-off date is fixed and does not move with enlargement: a food consumed significantly in one founding Member State before 1997 is not novel merely because a later-joining Member State had no prior history of its use.
The ten categories set out in Article 3(2)(a) capture a wide range of ingredient types, and manufacturers of foods, supplements, and functional ingredients are generally most likely to meet one of the first few and the last two:
- Food with a new or intentionally modified molecular structure not previously used as, or in, a food within the Union before 15 May 1997.
- Food consisting of, isolated from, or produced from microorganisms, fungi, or algae.
- Food consisting of, isolated from, or produced from material of mineral origin.
- Food consisting of, isolated from, or produced from plants or their parts, with an exception for food that has a history of safe food use in the Union and comes from traditional propagating practices used before 15 May 1997, or from non-traditional propagating practices that do not significantly change composition, structure, nutritional value, metabolism, or the level of undesirable substances.
- Food consisting of, isolated from, or produced from animals or their parts, with a comparable exception for traditional breeding practices used before 15 May 1997 where the resulting food has a history of safe use in the Union.
- Food consisting of, isolated from, or produced from cell culture or tissue culture derived from animals, plants, microorganisms, fungi, or algae.
- Food resulting from a production process not used for food production in the Union before 15 May 1997 that gives rise to significant changes in composition or structure affecting nutritional value, metabolism, or the level of undesirable substances.
- Food consisting of engineered nanomaterials, as defined in Article 3(2)(f).
- Vitamins, minerals, and other substances used under Directive 2002/46/EC, Regulation (EC) No 1925/2006, or Regulation (EU) No 609/2013, where a novel production process has been applied or where the substance contains or consists of engineered nanomaterials.
- Food used exclusively in food supplements within the Union before 15 May 1997, where it is now intended for use in foods other than food supplements.
Category (ix) is the one that most often surprises supplement formulators: a vitamin, mineral, or botanical-derived substance that has long been accepted as a supplement ingredient can still trigger novel food status if it is made by a production process not previously used for food, or if it has an engineered nanomaterial form, and category (x) separately catches a substance long used in supplements that a manufacturer now wants to add to an ordinary food or drink.
Article 4 gives food business operators the responsibility to verify, before placing a product on the market, whether it falls within scope, and directs them to consult the Member State where they first intend to market the food if that status is unclear. Article 5 gives the Commission an implementing power to determine, on its own initiative or on request, whether a particular food meets the novel food definition. As of October 2026, applicants can also cross-check a product against the EU's Novel Food Status Catalogue maintained by the Commission, though that catalogue is an administrative aid rather than a binding determination in every case.
03The traditional-food notification route for third-country foods
Where the food in question is a traditional food from a third country — defined in Article 3(2)(c) as a novel food, other than certain categories such as engineered nanomaterials or food with a novel molecular structure, derived from primary production with a history of safe food use in a third country — an applicant may choose a lighter notification route under Articles 14 to 20 instead of the full application procedure. Article 3(2)(b) sets that history-of-safe-use threshold at confirmed safety, supported by compositional data, from at least 25 years of continued use in the customary diet of a significant number of people in at least one third country.
A notification under Article 14 must include the applicant's name and address, the name and description of the traditional food, its detailed composition, the country or countries of origin, documented data demonstrating the history of safe use, and a proposal for conditions of use and labelling. Article 15 then sets a structured timeline: the Commission forwards a valid notification to the Member States and EFSA without delay and no later than one month after verifying its validity; Member States or EFSA then have four months from that forwarding date to submit duly reasoned safety objections. If no such objection is raised within the four months, the Commission authorises the traditional food and updates the Union list without delay, with the entry specifying that it is a traditional food from a third country.
If a duly reasoned safety objection is submitted within the four-month window, the Commission does not authorise the food on the strength of the notification alone. Under Article 16, the applicant may then submit a full application addressing the objections, and Article 17 gives EFSA six months from receipt of that valid application to adopt its opinion — a shorter period than the nine months applied to the general route, reflecting that the dossier builds on an existing history-of-use notification rather than starting from first principles. As with the general route, this six-month period can be extended where EFSA requests additional information from the applicant.
| Route | Legal basis | Core timeline as stated in the regulation | Typical fit |
|---|---|---|---|
| Standard authorisation | Articles 9-12 | EFSA opinion within 9 months of a valid application (extendable); Commission decision follows by implementing act | New ingredients, novel production processes, nanomaterials, substances without an established third-country use history |
| Traditional food notification | Articles 14-15 | Commission forwards within 1 month; Member States/EFSA have 4 months to raise safety objections; if none, Union list is updated without delay | Foods with at least 25 years of documented safe dietary use in a third country |
| Traditional food — contested notification | Articles 16-17 | If objections are raised, applicant may submit a full application; EFSA opinion due within 6 months of a valid application | Traditional foods where Member States or EFSA raise a duly reasoned safety concern |
04The Union list and data protection for proprietary dossiers
Article 6 requires the Commission to establish and keep updated a Union list of authorised novel foods, and Article 6(2) is the operative market-access rule: only novel foods that are authorised and included in the Union list may be placed on the market within the Union, whether sold as such or used as an ingredient, and only in accordance with the conditions of use and labelling requirements specified in that list entry. Article 9 explains what an update to the list can consist of — adding a novel food, removing one, or changing the specifications, conditions of use, labelling requirements, or post-market monitoring requirements attached to an existing entry.
Article 7 sets the general conditions the Commission applies before authorising and listing a novel food: that it does not, on the available scientific evidence, pose a safety risk to human health; that its intended use does not mislead the consumer, particularly where it is meant to replace another food and there is a significant change in nutritional value; and that where it is intended to replace another food, normal consumption of the novel food would not be nutritionally disadvantageous compared with the food it replaces.
Article 26 allows an applicant to request data protection for newly developed scientific evidence or data submitted in support of a standard-route application. Where the Commission grants that protection under Article 27, the newly developed evidence cannot be used for the benefit of a subsequent applicant's application for five years from the date of authorisation, without the agreement of the initial applicant. That protection depends on the evidence having been designated proprietary at the time of the first application, on the initial applicant having had an exclusive right of reference to it at that time, and on the novel food not being assessable and authorisable without that proprietary evidence. Article 26(3) is explicit that this data protection mechanism does not apply to notifications or applications concerning traditional foods from third countries — the lighter route built around a documented history of use rather than newly generated safety data.
05What this means for supplement and ingredient manufacturers
For a business bringing a new ingredient, extract, or production process to the EU market, Regulation (EU) 2015/2283 changes the order of operations compared with markets that allow self-affirmed safety determinations for new ingredients. Article 4 puts the initial burden of checking novel food status on the food business operator itself, and getting that assessment wrong by placing an unauthorised novel food on the market is a compliance risk independent of whether the ingredient later turns out to be safe.
Practically, that means ingredient and supplement teams benefit from building a novel-food screening step into early-stage product development rather than at the point of launch, because the standard route's EFSA assessment period alone runs to nine months before any extension, and the traditional-food route still carries a minimum four-month objection window even in the best case. Where a product touches category (ix) or (x) of Article 3(2)(a) — a vitamin, mineral, or botanical substance made by a new process, in nanomaterial form, or being moved from supplement-only use into general food use — teams should treat it as a candidate for novel food screening even if the underlying substance already has a long history as a supplement ingredient in the Union.
Because the Union list entry itself specifies the conditions of use, labelling requirements, and any post-market monitoring obligations for an authorised novel food, compliance does not end at the authorisation decision: a manufacturer using a listed novel food needs ongoing visibility over the exact specification, permitted food categories, maximum use levels, and label wording tied to that entry, and needs to track any later amendment to the entry under Article 9(2)(c). For supplement manufacturers coordinating formulation, labelling, and batch release records across multiple product lines, this sits alongside the broader set of EU and national obligations covered in the dietary supplement operations guide, which looks at how formulation, labelling, and quality documentation fit together across a product's lifecycle.
Finally, because data protection under Article 26 only attaches to newly developed scientific evidence submitted with a standard-route application, and does not apply to traditional food notifications, a manufacturer weighing which route to pursue for a borderline ingredient should factor in not just the comparative timelines but also whether protecting proprietary safety data for five years is commercially material to the investment case for that ingredient.
Frequently asked questions
Q.Does the cut-off date for novel food status change for countries that joined the EU after 1997?+
No. Article 3(2)(a) fixes the reference date at 15 May 1997 for the whole Union irrespective of a Member State's date of accession, so a food's novel status turns on whether it was used to a significant degree anywhere in the Union before that date, not on the accession history of any one Member State.
Q.How long does novel food authorisation take under Regulation (EU) 2015/2283?+
The regulation states specific windows for individual stages rather than one overall deadline. Under the standard route, EFSA's opinion is due within nine months of a valid application, extendable where EFSA requests more data from the applicant. Under the traditional-food notification route, Member States and EFSA have four months to raise safety objections, and if a contested notification proceeds to a full application, EFSA's opinion is due within six months. The Commission's own validation and implementing-act steps run in addition to these periods, so the total time to market access is longer than any single figure in the regulation.
Q.What is the difference between the standard authorisation route and the traditional-food notification route?+
The standard route under Articles 9 to 12 requires a full dossier including composition, production process, and scientific safety evidence, assessed by EFSA. The traditional-food notification route under Articles 14 to 20 is available for foods with at least 25 years of documented safe dietary use in a third country, and relies on that use history rather than a full safety dossier, unless a duly reasoned safety objection is raised, in which case the applicant moves to a full application with a shorter six-month EFSA assessment period.
Q.Can a vitamin or botanical ingredient already used in supplements still be a novel food?+
Yes, in specific circumstances. Article 3(2)(a)(ix) covers vitamins, minerals, and other substances used under existing supplement or food-fortification legislation where a new production process has been applied or where the substance is in an engineered nanomaterial form, and Article 3(2)(a)(x) covers a substance used exclusively in supplements before 15 May 1997 that a manufacturer now wants to use in foods other than supplements. Either situation can trigger novel food status even though the substance itself is not new to the EU market.
Q.What happens once a novel food is added to the Union list?+
Under Article 6(2), only novel foods included in the Union list may be placed on the market, and only in line with the conditions of use and labelling requirements specified in that list entry. The entry can later be amended under Article 9(2)(c) to change specifications, conditions of use, labelling requirements, or post-market monitoring requirements, so manufacturers using a listed novel food need to track the current entry rather than relying on the authorisation decision alone.
Primary sources
- Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, consolidated text — eur-lex.europa.eu, reviewed 9 Oct 2026
- Regulation (EU) 2015/2283, full PDF text (Articles 3, 9-19, 26-27) — eur-lex.europa.eu, reviewed 9 Oct 2026
- EUR-Lex summary, "New (novel) foods — rules from 2018" — eur-lex.europa.eu, reviewed 9 Oct 2026
- EFSA, "Novel food application procedure" — efsa.europa.eu, reviewed 9 Oct 2026
- EFSA, "Novel food" topic page — efsa.europa.eu, reviewed 9 Oct 2026
Further reading
Want to see how EU Novel Food Regulation (EC) 2015/2283 could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.
